Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 1,222 | 1,047 | 1,222 | 1,181 | 1,203 |
| Operating Income | -1,222 | -1,047 | -1,222 | -1,181 | -1,203 |
| Interest Expense | 505 | 4 | 453 | 0 | 469 |
| Other Income | 489 | -1 | 95 | -489 | 1 |
| Pre-tax Income | -1,239 | -1,051 | -1,580 | -1,670 | -1,671 |
| Net Income Continuous | -1,239 | -1,051 | -1,580 | -1,670 | -1,671 |
| Net Income | $-1,239 | $-1,051 | $-1,580 | $-1,670 | $-1,671 |
| EBITDA(a) | $-1,219 | $-1,044 | $-1,219 | $-1,178 | $-1,199 |